4-[2-amino-2-cyclopropyl-4-(5-fluoro-2-methoxyphenyl)-4-methylpentyl]-3-chlorobenzonitrile | 633316-48-0

• 分子结构分类: 有机化合物 - 木脂素、新木脂素和相关化合物
• 英文名称: 4-[2-amino-2-cyclopropyl-4-(5-fluoro-2-methoxyphenyl)-4-methylpentyl]-3-chlorobenzonitrile
• CAS: 633316-48-0
• 化学式: C₂₃H₂₆ClFN₂O
• 分子量: 400.924
• InChiKey: UJQGNGBSPVKIRQ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5.5
• 重原子数：
  28
• 可旋转键数：
  7
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.43
• 拓扑面积：
  59
• 氢给体数：
  1
• 氢受体数：
  4

文献信息

• Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
  申请人：Boehringer Ingelheim Pharmaceuticals, Inc.

  公开号：US20040010020A1

  公开（公告）日：2004-01-15

  A compound of Formula (IA) or Formula (IB) 1 wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 ,and R 8 are as defined herein, or a tautomer, prodrug, solvate, or salt thereof; pharmaceutical compositions containing such compounds, and methods of modulating the glucocorticoid receptor function and methods of treating disease-states or conditions mediated by the glucocorticoid receptor function or characterized by inflammatory, allergic, or proliferative processes in a patient using these compounds.

  一种具有Formula (IA)或Formula (IB)的化合物，其中R1、R2、R3、R4、R5、R6、R7和R8如本文所定义，或其互变异构体、前药、溶剂化合物或盐；含有这些化合物的药物组合物，以及使用这些化合物调节糖皮质激素受体功能的方法，以及使用这些化合物治疗由糖皮质激素受体功能介导或以炎症、过敏或增生过程为特征的疾病状态或病情的方法。
• GLUCOCORTICOID MIMETICS, METHODS OF MAKING THEM, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF
  申请人：BOEHRINGER INGELHEIM PHARMACEUTICALS INC.

  公开号：EP1511716A2

  公开（公告）日：2005-03-09
• US7186864B2
  申请人：——

  公开号：US7186864B2

  公开（公告）日：2007-03-06
• [EN] GLUCOCORTICOID MIMETICS, METHODS OF MAKING THEM, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF<br/>[FR] COMPOSES MIMETIQUES DE GLUCOCORTICOIDE, LEURS PROCEDES DE FABRICATION, COMPOSITIONS PHARMACEUTIQUES, ET LEURS UTILISATIONS
  申请人：BOEHRINGER INGELHEIM PHARMA

  公开号：WO2003101932A2

  公开（公告）日：2003-12-11

  A compound of Formula (IA) or Formula (IB) wherein R1, R2, R3, R4, R5, R6, R7, and R8 are as defined herein, or a tautomer, prodrug, solvate, or salt thereof; pharmaceutical compositions containing such compounds, and methods of modulating the glucocorticoid receptor function and methods of treating disease-states or conditions mediated by the glucocorticoid receptor function or characterized by inflammatory, allergic, or proliferative processes in a patient using these compounds.